ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Down 10.2% – Here’s Why

Shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) traded down 10.2% on Tuesday. The stock traded as low as $10.38 and last traded at $10.44. Approximately 91,399 shares traded hands during mid-day trading, a decline of 59% from the average session volume of 221,147 shares. The stock had previously closed at $11.62.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on CHRN shares. Weiss Ratings lowered ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a research report on Friday, October 23rd. Northland Securities assumed coverage on ChronoScale Corporation Common Stock in a research note on Friday, September 18th. They set an “outperform” rating and a $32.00 target price on the stock. Finally, Compass Point began coverage on shares of ChronoScale Corporation Common Stock in a report on Friday, October 16th. They issued a “buy” rating and a $25.00 price target on the stock. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $21.00.

ChronoScale Corporation Common Stock Trading Down 9.3%

The firm has a fifty day simple moving average of $17.47 and a two-hundred day simple moving average of $16.07. The firm has a market capitalization of $1.54 billion, a P/E ratio of -2.44 and a beta of 1.12. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.30 and a quick ratio of 0.30.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its earnings results on Wednesday, October 14th. The company reported ($0.29) earnings per share (EPS) for the quarter. The firm had revenue of $41.48 million during the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. On average, equities research analysts anticipate that ChronoScale Corporation Common Stock will post -0.49 earnings per share for the current fiscal year.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.